Literature DB >> 9659902

Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs.

R B Rawson1, N G Zelenski, D Nijhawan, J Ye, J Sakai, M T Hasan, T Y Chang, M S Brown, J L Goldstein.   

Abstract

We report the cloning of a gene, S2P, that encodes a putative metalloprotease required for intramembrane proteolysis of sterol-regulatory element-binding proteins (SREBPs) at Site-2. SREBPs are membrane-bound transcription factors that activate genes regulating cholesterol metabolism. The active NH2-terminal domains of SREBPs are released from membranes by sequential cleavage at two sites: Site-1, within the lumen of the endoplasmic reticulum; and Site-2, within a transmembrane segment. The human S2P gene was cloned by complementation of mutant CHO cells that cannot cleave SREBPs at Site-2 and are cholesterol auxotrophs. S2P defines a new family of polytopic membrane proteins that contain an HEXXH sequence characteristic of zinc metalloproteases. Mutation of the putative zinc-binding residues abolishes S2P activity. S2P encodes an unusual metalloprotease that cleaves proteins within transmembrane segments.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9659902     DOI: 10.1016/s1097-2765(00)80006-4

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  144 in total

1.  Evidence that SpoIVFB is a novel type of membrane metalloprotease governing intercompartmental communication during Bacillus subtilis sporulation.

Authors:  Y T Yu; L Kroos
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

2.  A notable cleavage: winding up with beta-amyloid.

Authors:  K S Kosik
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

3.  Mechanism of the cleavage specificity of Alzheimer's disease gamma-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein.

Authors:  S F Lichtenthaler; R Wang; H Grimm; S N Uljon; C L Masters; K Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

4.  Intramembrane cleavage of microneme proteins at the surface of the apicomplexan parasite Toxoplasma gondii.

Authors:  Corinna Opitz; Manlio Di Cristina; Matthias Reiss; Thomas Ruppert; Andrea Crisanti; Dominique Soldati
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

5.  A sporulation membrane protein tethers the pro-sigmaK processing enzyme to its inhibitor and dictates its subcellular localization.

Authors:  David Z Rudner; Richard Losick
Journal:  Genes Dev       Date:  2002-04-15       Impact factor: 11.361

Review 6.  Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease.

Authors:  Dennis J Selkoe
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 7.  New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c.

Authors:  Fabienne Foufelle; Pascal Ferré
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

8.  Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors.

Authors:  Valeria Giandomenico; Maria Simonsson; Eva Grönroos; Johan Ericsson
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

9.  Protein phosphatase 2A (PP2A) regulates low density lipoprotein uptake through regulating sterol response element-binding protein-2 (SREBP-2) DNA binding.

Authors:  Lyndi M Rice; Melissa Donigan; Muhua Yang; Weidong Liu; Devanshi Pandya; Biny K Joseph; Valerie Sodi; Tricia L Gearhart; Jenny Yip; Michael Bouchard; Joseph T Nickels
Journal:  J Biol Chem       Date:  2014-04-26       Impact factor: 5.157

10.  The Streptomyces coelicolor developmental transcription factor sigmaBldN is synthesized as a proprotein.

Authors:  Maureen J Bibb; Mark J Buttner
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.